Dr. Daniel Koller looks back at 2020 and explains the breakthroughs in the biotech industry, why BB Biotech had already invested in Moderna in 2018, and the new additions to the portfolio.
The fourth quarter 2020 provided multiple major milestones for our portfolio holdings such as clinical results, regulatory decisions, licensing deals and M&A transactions.
